Browse by author
Lookup NU author(s): Dr David Almarza Gomez,
Professor John LoughlinORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The ability to efficiently and reproducibly edit genomes using engineered nucleases is one of the major biological advances of the past few decades and is generating considerable excitement for those working in medical research, from investigators studying the molecular and cellular basis of disease through to those generating novel treatments via regenerative medicine and gene therapy. Genome editing is a technology that enables scientists to generate specific DNA modifications at preselected loci in the genome of living cells, with a high degree of specificity and without damaging the cell’s ability to function, replicate or differentiate.
Author(s): Almarza D, Cucchiarini M, Loughlin J
Publication type: Editorial
Publication status: Published
Journal: Osteoarthritis and Cartilage
Print publication date: 01/08/2017
Online publication date: 18/05/2017
Acceptance date: 08/05/2017
ISSN (print): 1063-4584
ISSN (electronic): 1522-9653
PubMed id: 28529161